Display options
Cite
Kaboré J, Metzger M, Helmer C, et al. Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease. Kidney Int Rep. 2016;2(2):180-191doi: 10.1016/j.ekir.2016.10.006.
Kaboré, J., Metzger, M., Helmer, C., Berr, C., Tzourio, C., Drueke, T. B., Massy, Z. A., & Stengel, B. (2017). Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease. Kidney international reports, 2(2), 180-191. https://doi.org/10.1016/j.ekir.2016.10.006
Kaboré, Jean, et al. "Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease." Kidney international reports vol. 2,2 (2017): 180-191. doi: https://doi.org/10.1016/j.ekir.2016.10.006
Kaboré J, Metzger M, Helmer C, Berr C, Tzourio C, Drueke TB, Massy ZA, Stengel B. Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease. Kidney Int Rep. 2016 Oct 31;2(2):180-191. doi: 10.1016/j.ekir.2016.10.006. eCollection 2017 Mar. PMID: 29142956; PMCID: PMC5678838.
Copy Download .nbib Format: NLM
Share it on

Kidney Int Rep. 2016 Oct 31;2(2):180-191. doi: 10.1016/j.ekir.2016.10.006. eCollection 2017 Mar.

Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease.

Kidney international reports

Jean Kaboré, Marie Metzger, Catherine Helmer, Claudine Berr, Christophe Tzourio, Tilman B Drueke, Ziad A Massy, Bénédicte Stengel

Affiliations

  1. CESP, Inserm UMR1018 Team 5, University of Paris-Sud, UVSQ, University Paris-Saclay, Villejuif, France.
  2. Inserm, UMR1219 Population Health, Bordeaux, France.
  3. University of Bordeaux, UMR1219, Bordeaux, France.
  4. Clinical Investigation Center-Clinical Epidemiology 1401, Bordeaux, France.
  5. Inserm U1061, Montpellier, France.
  6. University Montpellier I, Montpellier, France.
  7. Division of Nephrology, Ambroise Paré University Hospital, APHP, Boulogne-Billancourt, France.

PMID: 29142956 PMCID: PMC5678838 DOI: 10.1016/j.ekir.2016.10.006

Abstract

INTRODUCTION: Chronic kidney disease (CKD) is often associated with poor hypertension control and treatment resistance, but whether CKD modifies the effect of hypertension control on outcomes is unknown.

METHODS: We studied 10-year mortality and cardiovascular events according to hypertension control status and CKD (glomerular filtration rate <60 ml/min/1.73m

RESULTS: At baseline, 19% had CKD, and 31.2% had controlled hypertension on ≤3 antihypertensive drugs, 62.3% uncontrolled hypertension ≥140/90 mm Hg on ≤2 drugs, and 6.5% apparent treatment-resistant hypertension (aTRH) ≥140/90 mm Hg with ≥3 drugs or use of ≥4 drugs regardless of level. There were 1115 deaths (305 total cardiovascular deaths) and 274 incident nonfatal or fatal strokes or coronary events. Compared to the reference group (controlled hypertension and no CKD), participants without CKD and with uncontrolled hypertension or aTRH had adjusted hazard ratios for all-cause mortality of 0.86 (0.74-1.01) and 1.09 (0.82-1.46), and those with CKD and controlled or uncontrolled hypertension, or aTRH, of 1.33 (1.06-1.68), 1.14 (0.93-1.39), and 1.34 (0.98-1.85), respectively. Participants with aTRH and CKD had a risk of coronary death more than 3 times higher than that of the reference group; participants with aTHR, with or without CKD, had a risk of stroke more than twice as high, and those with CKD but controlled hypertension a 2 times higher risk for cardiovascular deaths from other causes.

DISCUSSION: CKD does not appear to amplify the risk of stroke and coronary events associated with aTRH in this older population. The reasons for excess cardiovascular mortality from other causes associated with controlled hypertension require further study.

Keywords: cardiovascular; chronic kidney disease; hypertension

References

  1. J Hypertens. 2006 Jan;24(1):51-8 - PubMed
  2. Ann Intern Med. 2013 Aug 20;159(4):233-42 - PubMed
  3. JAMA Intern Med. 2015 Jun;175(6):989-95 - PubMed
  4. Eur J Epidemiol. 2009;24(11):669-75 - PubMed
  5. Lancet. 2015 Oct 17;386(10003):1588-98 - PubMed
  6. Hypertension. 2003 Dec;42(6):1206-52 - PubMed
  7. Lancet. 2012 Nov 10;380(9854):1649-61 - PubMed
  8. Am J Kidney Dis. 2010 Mar;55(3):441-51 - PubMed
  9. Nat Rev Nephrol. 2011 Mar;7(3):145-54 - PubMed
  10. PLoS One. 2014 Aug 04;9(8):e104362 - PubMed
  11. Nat Rev Nephrol. 2010 Dec;6(12):723-35 - PubMed
  12. Hypertension. 2015 Nov;66(5):998-1005 - PubMed
  13. Hypertens Res. 2005 Aug;28(8):657-63 - PubMed
  14. PLoS One. 2016 Jan 25;11(1):e0146056 - PubMed
  15. Lancet. 2016 Jan 30;387(10017):435-43 - PubMed
  16. Hypertension. 2016 Feb;67(2):387-96 - PubMed
  17. J Am Geriatr Soc. 2013 Dec;61(12):2160-7 - PubMed
  18. Hypertension. 2014 Nov;64(5):1012-21 - PubMed
  19. Lancet. 2012 Nov 10;380(9854):1662-73 - PubMed
  20. Lancet. 2010 Jun 12;375(9731):2073-81 - PubMed
  21. Am J Kidney Dis. 2006 Oct;48(4):606-15 - PubMed
  22. Semin Dial. 2012 Jan-Feb;25(1):35-41 - PubMed
  23. Nephrol Dial Transplant. 2011 Oct;26(10):3286-95 - PubMed
  24. Clin J Am Soc Nephrol. 2013 Sep;8(9):1583-90 - PubMed
  25. Neuroepidemiology. 2003 Nov-Dec;22(6):316-25 - PubMed
  26. Nephrol Dial Transplant. 2011 Sep;26(9):2852-9 - PubMed
  27. Hypertension. 2009 Jul;54(1):47-56 - PubMed
  28. Clin J Am Soc Nephrol. 2009 Apr;4(4):830-7 - PubMed
  29. Eur Heart J. 2013 Apr;34(16):1204-14 - PubMed
  30. J Am Coll Cardiol. 2013 Jun 18;61(24):2461-2467 - PubMed
  31. Am J Kidney Dis. 1999 Mar;33(3):507-17 - PubMed
  32. J Hypertens. 2003 Jan;21(1):49-56 - PubMed
  33. Circulation. 2011 Aug 30;124(9):1046-58 - PubMed
  34. JAMA Intern Med. 2014 Sep;174(9):1442-9 - PubMed
  35. Epidemiology. 2012 Jul;23(4):565-73 - PubMed
  36. Drugs Today (Barc). 2016 Mar;52(3):193-8 - PubMed
  37. J Am Soc Hypertens. 2014 Jun;8(6):405-13 - PubMed
  38. Am J Hypertens. 2007 Jun;20(6):616-21 - PubMed
  39. JAMA. 2014 Feb 5;311(5):507-20 - PubMed
  40. Kidney Int. 1998 Aug;54(2):561-9 - PubMed
  41. Hypertension. 2006 Jan;47(1):62-8 - PubMed
  42. Nat Rev Nephrol. 2016 Mar;12(3):127-8 - PubMed
  43. N Engl J Med. 2015 Nov 26;373(22):2103-16 - PubMed
  44. Hypertension. 2011 Jun;57(6):1076-80 - PubMed
  45. J Gerontol A Biol Sci Med Sci. 1998 Sep;53(5):M337-43 - PubMed
  46. Circulation. 2012 Apr 3;125(13):1635-42 - PubMed
  47. Ann Intern Med. 2006 Aug 15;145(4):247-54 - PubMed

Publication Types